Pizzuti, L., Sergi, D., Sperduti, I., Lauro, L., Mazzotta, M., Botti, C., … Vici, P. (2018). Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Cancer Biology & Therapy. https://doi.org/10.1080/15384047.2017.1416938 (Original work published 2018)